We provide targeted DNA sequencing allowing us to focus specific areas of interest at a reduced price and faster delivery time. Our laboratory’s technology can accommodate small blood sample sizes, making it viable alternative to a trip to the phlebotomist and reducing the impact of blood-drawing on patients’ health.
NEXT GENERATION SEQUENCING – GERMLINE MUTATION
Our Autism Amplicon Sequencing Panel assists in the investigation of genomic features associated with autism through sequencing 98 developmental delay genes linked specifically with autism. This assay is performed using genomic DNA isolated from human peripheral whole blood specimens.
The test is intended to identify variants that are associated with autism. The test is performed as a pre-symptomatic genetic testing to evaluate if individuals have the gene alterations associated with the autism. The test can also be used for post-symptomatic genetic testing to confirm variants of association to autism.
Autism is a broad-spectrum disorder. Recent studies have identified that epigenetic factors have an important role in the development of autism. A negative genetic test does not confirm the misdiagnosis of the affected individual.
All tests are performed in Ayass BioScience, LLC. Ayass BioScience, LLC (DBA Ayass Lung Clinic, PLLC) is a CLIA certified laboratory. If you have any questions about Genetic Testing Next Generation Sequencing at Ayass BioScience, LLC, please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.